A young person starts feeling confused and forgetful. They have trouble finding words and their legs feel weak. Doctors are puzzled until they learn the person has been using nitrous oxide, often called laughing gas, on a regular basis. This is not a rare story anymore.
Nitrous oxide is a dissociative hallucinogen that is increasingly used recreationally. It is widely available and often seen as harmless. But it can cause serious brain and nerve problems that last longer than many people expect.
The condition is called subacute combined degeneration. It happens when nitrous oxide inactivates vitamin B12 in the body. Without enough active B12, nerves lose their protective covering. This can cause numbness, weakness, and balance problems. It can also lead to confusion, memory issues, and a state called encephalopathy, which is a general term for brain dysfunction.
Current guidelines say to treat these neurological problems with vitamin B12 supplementation. But there is a catch. There is very little long-term data on how well this works over many months or years. Doctors often do not know how long to continue treatment or what to expect for recovery.
Here is the twist. We used to think that if you stop nitrous oxide and start B12, the brain and nerves will heal quickly. But this case shows that some people have a protracted course. The confusion and weakness can linger, and the path back is not always straight.
Think of vitamin B12 as a key that unlocks a repair factory in your nerves. Nitrous oxide jams the lock. When the lock is jammed, the factory cannot make the protective coating for nerve fibers. Giving B12 is like making new keys. But if the damage is deep, the factory may need time and steady support to get back to full production.
The case report comes from Frontiers in Medicine, published on May 15, 2026. It describes one person with chronic nitrous oxide use who developed both encephalopathy and subacute combined degeneration. The medical team tracked cognitive changes using the Mini-Mental Status Exam, a simple bedside test that checks orientation, memory, and attention. They also reviewed the patient’s other medical and psychiatric conditions, which can make diagnosis and treatment planning more complex.
The team started vitamin B12 supplementation in the hospital. Over time, the patient’s scores on the mental status exam improved. This suggests that B12 can help with the brain fog that comes from nitrous oxide use. The improvement was steady but not instant. It took patience and careful monitoring.
The patient also had other health issues that complicated recovery. These can include anxiety, depression, or other substance use. When multiple conditions overlap, it is harder to tell which symptom comes from where. This is why a careful, step-by-step approach matters.
This does not mean vitamin B12 is a cure for everyone.
The case shows that B12 may help, but it does not prove that all patients will recover the same way. Each person’s story is different. The amount and length of nitrous oxide use, other medical problems, and access to care all play a role.
Experts in the field note that we need more long-term studies. We need to know the best dose of B12, how long to continue it, and which patients benefit most. We also need better tools to track recovery over months and years, not just weeks.
For now, what does this mean for you or someone you care about. If you or a loved one uses nitrous oxide and develops confusion, memory problems, or numbness and weakness, talk to a doctor right away. Ask about vitamin B12 testing and treatment. Be honest about use so the team can plan the right care. This is a safe, practical step that can make a real difference.
It is also important to address any other medical or mental health needs. A team approach that includes primary care, neurology, and mental health support can help. Recovery may take time, and ongoing follow-up is key.
There are limits to this case report. It describes one person, so we cannot generalize to everyone. The study does not prove cause and effect. And long-term outcome data are still scarce. These are real gaps that the medical community needs to fill.
Looking ahead, researchers will likely study larger groups of people over longer periods. They will test different B12 regimens and track brain and nerve function with simple tools and advanced imaging. Approval pathways are not the issue here, since B12 is already used. The goal is to build clear, evidence-based plans for extended treatment. Until then, clinicians and patients should work together, monitor progress closely, and stay hopeful but realistic.
